Socially vulnerable Medicare patients see dramatically better outcomes—such as fewer emergency department visits, fewer preventable hospital admissions, and 23.4% to 30% less use of high-risk medications—when their physicians take on full financial risk for their care compared with those in traditional fee-for-service Medicare. That's the core finding of a new study published in the June issue of…
UPMC and Birth Root Community Doula describe a 4-year partnership addressing food insecurity, housing, and maternal health disparities in Erie, Pennsylvania.
In this episode of Managed Care Cast, Alvin Thomas, PhD, clinical psychologist at the University of Wisconsin-Madison, discusses the mental health challenges facing Black and Latino boys and young men.
For this Managed Care Cast episode, The American Journal of Managed Care® (AJMC®) spoke with Anuraag R. Kansal, PhD, who leads health economics research at GRAIL, about his study, “State Medicaid Budgetary Implications of New Cancers," published in the July 2026 issue; it examined how new cancer diagnoses affected state Medicaid budgets. He conducted the study with Amanda C. Chen, PhD, of the USC…
On this episode of Managed Care Cast, The American Journal of Managed Care® (AJMC®) was joined by Erin L. Duffy, PhD, MPH, an author of a study published in the June 2026 issue. She is a health policy researcher at the Schaeffer Center for Health Policy & Economics at the University of Southern California, with a focus on health care affordability, access to care, and how health systems can better…
Most patients with metabolic dysfunction–associated steatotic liver disease (MASLD) go undiagnosed until significant liver damage has already occurred, despite the availability of simple, guideline-supported screening tools that remain notoriously underused in both primary care and weight management settings. That's according to a conversation between Naim Alkhouri, MD, chief medical officer at…
In this episode, Bhavana "Tina" Bhatnagar, DO, discusses how the field of acute myeloid leukemia has been fundamentally transformed; what this means for patients in rural, underserved settings; and where hematologic oncology is headed next.
Perry Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, watched epidemics emerge, witnessed governments fail to respond, and seen communities mobilize when institutions would not. From the early days of the AIDS crisis to COVID-19, Ebola, and beyond, he has drawn consistent lessons about what makes public health succeed and what causes it to collapse.
For patients with cancer, diagnosis doesn't just bring a physical battle. It can trigger a trauma response that can linger long after treatment ends, quietly reshaping how people sleep, think, and connect with the world around them.